Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.480
+0.220 (9.73%)
Oct 23, 2025, 3:11 PM EDT - Market open
Kiora Pharmaceuticals Market Cap
Kiora Pharmaceuticals has a market cap or net worth of $8.52 million as of October 23, 2025. Its market cap has decreased by -13.11% in one year.
Market Cap
8.52M
Enterprise Value
-11.96M
1-Year Change
-13.11%
Ranking
Category
Stock Price
$2.48
Market Cap Chart
Since February 13, 2015, Kiora Pharmaceuticals's market cap has decreased from $38.90M to $8.52M, a decrease of -78.11%. That is a compound annual growth rate of -13.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 7.80M | -21.21% |
| Dec 31, 2024 | 9.90M | 147.50% |
| Dec 29, 2023 | 4.00M | 2.56% |
| Dec 30, 2022 | 3.90M | -79.58% |
| Dec 31, 2021 | 19.10M | -16.23% |
| Dec 31, 2020 | 22.80M | -37.36% |
| Dec 31, 2019 | 36.40M | 80.20% |
| Dec 31, 2018 | 20.20M | 9.78% |
| Dec 29, 2017 | 18.40M | 17.95% |
| Dec 30, 2016 | 15.60M | -25.71% |
| Dec 31, 2015 | 21.00M | -46.02% |
| Feb 13, 2015 | 38.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.23B |
| Johnson & Johnson | 466.54B |
| AbbVie | 409.95B |
| UnitedHealth Group | 330.10B |
| AstraZeneca | 261.56B |
| Novartis AG | 254.74B |
| Novo Nordisk | 249.65B |
| Abbott Laboratories | 225.41B |